Publication | Open Access

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology

21-Gene Recurrence ScoreOncologyMedicineMetronomic TherapyAdjuvant ChemotherapyPathologyCancer TreatmentPharmacologyRadiation OncologyCancer ResearchTaxane Benefit